OB/GYN and Women's Health
1-16 of 90
- On the Frontlines of Metastatic Breast Cancer
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
Charles Turck, PharmD, BCPS, BCCCP
Heather Parsons
Pavani Chalasani, MD, MPH
Alison Stopeck, MD
- On the Frontlines of Metastatic Breast Cancer
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
Ashley Baker, MSN, PMHNP
Nick McAndrew, MD, MSCE
- On the Frontlines of Metastatic Breast Cancer
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
Charles Turck, PharmD, BCPS, BCCCP
Jules Cohen, MD
- On the Frontlines of Metastatic Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Jules Cohen, MD
- On the Frontlines of Metastatic Breast Cancer
Modern Approaches to Long-Term Metastatic Breast Cancer Care
Charles Turck, PharmD, BCPS, BCCCP
Adam Brufsky, MD, PhD
Pavani Chalasani, MD, MPH
Kristina Fanucci, MD, MHS
Jennifer Caudle, DO, FACOFP
Maxwell Llyod, MD
Pavani Chalasani, MD, MPH
Timothy Yap, MBBS, PhD, FRCP
Seth Wander, MD, PhD
- On the Frontlines of Metastatic Breast Cancer
Tracking Tumor Resistance in Metastatic Breast Cancer Care
Ryan Quigley
Megan Kruse, MD
Pavani Chalasani, MD, MPH
Erica L. Mayer, MD, MPH
Pavani Chalasani, MD, MPH
Erica L. Mayer, MD, MPH
Casey Cosgrove, MD
Brian Slomovitz, MD
- Prev
- Next